Skip to main content
. 2014 Mar 18;9(3):e92134. doi: 10.1371/journal.pone.0092134

Table 1. WNV+ subject characteristics.

Subject Symptom number Genderb Age IgMc IgGc Donor Statusd
Before donation Index donation After donation Peak symptom numbera
267 0 0 0 0 F 52 - - AS
247 1 0 N/A 1 F 29 - - AS
257 0 0 1 1 M 58 - - AS
437 1 0 0 1 F 57 - - AS
227 1 0 1 1 F 69 - - AS
17 2 2 0 2 M 52 - - AS
207 1 1 2 2 F 57 - - AS
357 0 0 2 2 F 46 - - AS
387 2 0 0 2 F 18 - - AS
137 2 0 N/A 2 M 63 - - AS
407 0 1 2 2 F 65 - - AS
127 3 0 0 3 M 26 - - AS
327 3 0 0 3 M 58 - - AS
77 0 0 0 0 M 77 + - AS
497 0 0 0 0 F 69 + - AS
517 0 0 N/A 0 F 65 + - AS
487 2 0 0 2 F 65 + - AS
177 0 0 0 0 M 60 + + AS
367 0 0 0 0 M 36 + + AS
187 1 0 1 1 M 37 + + AS
297 2 0 0 2 F 61 + + AS
307 0 0 0 0 M 38 + E AS
627 2 1 0 2 F 60 + E AS
57 0 1 0 1 M 69 E + AS
87 1 0 4 4 F 59 - - S
477 0 0 4 4 M 65 - - S
47 0 0 5 5 F 25 - - S
277 6 5 0 6 F 32 - - S
37 0 0 8 8 M 49 - - S
117 8 5 2 8 F 46 - - S
317 0 0 9 9 F 38 - - S
397 9 2 N/A 9 M 26 - - S

N/A, not available.

a

Highest number of symptoms reported on either questionnaire.

b

Female (F) and male (M).

c

Antibody interpretation at index: positive (+), negative (−), or equivocal (E).

d

AS is for asymptomatic when peak symptom number ≤3 and S is for symptomatic when peak symptom number ≥4.